China Pharma Holdings CPHI
$ 0.2
1.62%
Quarterly report 2024-Q3
added 11-13-2024
China Pharma Holdings Balance Sheet 2011-2024 | CPHI
Annual Balance Sheet China Pharma Holdings
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-4.73 M | 6.42 M | 3.23 M | 5.36 M | 7.19 M | 7.42 M | 6.08 M | 7.74 M | 11.4 M | 731 K | -119 K | ||
Long Term Debt |
39.9 K | - | 44.2 K | 904 K | 2.15 M | 4.36 M | 6.92 M | 8.64 M | 10.8 M | 11.4 M | 12.5 M | - | - |
Long Term Debt Current |
77.7 K | 40.4 K | 85.3 K | 52.1 K | 91.3 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 1.71 M | 2.95 M | 5.13 M | 7.65 M | 9.21 M | 11.8 M | 11.7 M | 12.7 M | 96 K | 129 K |
Total Current Liabilities |
6.82 M | 12.7 M | 10.5 M | 11.4 M | 10 M | 10.1 M | 9.23 M | 10.4 M | 12.8 M | 14.2 M | 12 M | 14.6 M | 13.8 M |
Total Liabilities |
9.01 M | 13.5 M | 16.6 M | 13.1 M | 13 M | 15.2 M | 16.9 M | 19.6 M | 24.6 M | 25.8 M | 24.7 M | 14.7 M | 13.9 M |
Deferred Revenue |
90.5 K | 520 K | 210 K | 720 K | 505 K | 526 K | 581 K | 811 K | 596 K | 2.08 M | 2.23 M | 1.95 M | 1.78 M |
Retained Earnings |
-39.3 M | -36.2 M | -32.2 M | -28.8 M | -26 M | -5.27 M | 5.48 M | 24.8 M | 33.9 M | 62.8 M | 88.9 M | 109 M | 104 M |
Total Assets |
16.5 M | 17.8 M | 22.6 M | 21.1 M | 22.2 M | 45.4 M | 60 M | 78.5 M | 97.2 M | 132 M | 158 M | 163 M | 156 M |
Cash and Cash Equivalents |
1.42 M | 2.03 M | 4.86 M | 958 K | 1.07 M | 1.19 M | 2.03 M | 2.67 M | 6.25 M | 5.3 M | 5.99 M | 4.03 M | 4.05 M |
Book Value |
7.45 M | 4.29 M | 6.02 M | 8 M | 9.24 M | 30.2 M | 43.1 M | 58.9 M | 72.6 M | 106 M | 133 M | 149 M | 142 M |
Total Shareholders Equity |
7.45 M | 4.29 M | 6.02 M | 8 M | 9.24 M | 30.2 M | 43.1 M | 58.9 M | 72.6 M | 92.7 M | 133 M | 149 M | 142 M |
All numbers in USD currency
Quarterly Balance Sheet China Pharma Holdings
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | 39.9 K | 58.8 K | 77.6 K | - | - | - | - | 22.3 K | 44.2 K | 4.33 M | 5.02 M | 5.01 M | 5.24 M | 4.97 M | 6 M | 4.09 M | 4.3 M | 4.24 M | 6.4 M | 6.56 M | 6.54 M | 6.55 M | 8.91 M | 9.39 M | 9.22 M | 9.17 M | 10.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
6.94 M | 6.85 M | 9.01 M | 9.24 M | 11.4 M | 12.7 M | 13.5 M | 13.4 M | 13.9 M | 15.7 M | 16.6 M | 11.3 M | 13.4 M | 12.7 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 13 M | 13 M | 13 M | 13 M | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 16.9 M | 16.9 M | 16.9 M | 16.9 M | 19.6 M | 19.6 M | 19.6 M | 19.6 M | 23.9 M | 24.6 M | 24.6 M | 24.6 M | 28.3 M | 28.3 M | 28.3 M | 29 M | 24.7 M | 24.7 M | 24.7 M | 24.7 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 13.9 M | 13.9 M | 13.9 M | 13.9 M |
Deferred Revenue |
24.9 K | 101 K | 90.5 K | 172 K | 61.3 K | 137 K | 520 K | 84 K | 138 K | 136 K | 210 K | 420 K | 526 K | 572 K | 720 K | 720 K | 720 K | 720 K | 505 K | 505 K | 505 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-42.8 M | -41.7 M | -39.3 M | -38.1 M | -37.3 M | -36.7 M | -36.2 M | -34.9 M | -34.2 M | -33.3 M | -32.2 M | -31.3 M | -30.4 M | -29.6 M | -28.8 M | -28.8 M | -28.8 M | -28.8 M | -26 M | -26 M | -26 M | -26 M | -5.27 M | -5.27 M | -5.27 M | -5.27 M | 5.48 M | 5.48 M | 5.48 M | 5.48 M | 24.8 M | 24.8 M | 24.8 M | 24.8 M | 33.9 M | 33.9 M | 33.9 M | 33.9 M | 49.3 M | 49.3 M | 49.3 M | 48.7 M | 88.9 M | 88.9 M | 88.9 M | 88.9 M | 109 M | 109 M | 109 M | 109 M | 104 M | 104 M | 104 M | 104 M |
Total Assets |
13.5 M | 14.3 M | 16.5 M | 15.4 M | 15.7 M | 17.4 M | 17.8 M | 16.2 M | 17.9 M | 21 M | 22.6 M | 18.2 M | 19.9 M | 19.8 M | 21.1 M | 21.1 M | 21.1 M | 21.1 M | 22.2 M | 22.2 M | 22.2 M | 22.2 M | 45.4 M | 45.4 M | 45.4 M | 45.4 M | 60 M | 60 M | 60 M | 60 M | 78.5 M | 78.5 M | 78.5 M | 78.5 M | 96.5 M | 97.2 M | 97.2 M | 97.2 M | 121 M | 121 M | 121 M | 121 M | 158 M | 158 M | 158 M | 158 M | 163 M | 163 M | 163 M | 163 M | 156 M | 156 M | 156 M | 156 M |
Cash and Cash Equivalents |
700 K | 739 K | 1.42 M | 1.37 M | 902 K | 1.17 M | 2.03 M | 2.09 M | 2.24 M | 3.71 M | 4.86 M | 459 K | 1.75 M | 535 K | 958 K | 958 K | 958 K | 958 K | 1.07 M | 1.07 M | 1.07 M | 1.07 M | 1.19 M | 1.19 M | 1.19 M | 1.19 M | 2.03 M | 2.03 M | 2.03 M | 2.03 M | 2.67 M | 2.67 M | 2.67 M | 7.26 M | 6.25 M | 6.25 M | 6.25 M | 6.25 M | 5.3 M | 5.3 M | 5.3 M | 5.3 M | 5.99 M | 5.99 M | 5.99 M | 4.75 M | 4.03 M | 5.06 M | 4.87 M | 3.32 M | 4.05 M | 4.05 M | 4.05 M | 4.05 M |
Book Value |
6.53 M | 7.41 M | 7.45 M | 6.11 M | 4.35 M | 4.67 M | 4.29 M | 2.83 M | 4.02 M | 5.34 M | 6.02 M | 6.85 M | 6.52 M | 7.17 M | 8 M | 8 M | 8 M | 8 M | 9.24 M | 9.24 M | 9.24 M | 9.24 M | 30.2 M | 30.2 M | 30.2 M | 30.2 M | 43.1 M | 43.1 M | 43.1 M | 43.1 M | 58.9 M | 58.9 M | 58.9 M | 58.9 M | 72.6 M | 72.6 M | 72.6 M | 72.6 M | 92.7 M | 92.7 M | 92.7 M | 92.1 M | 133 M | 133 M | 133 M | 133 M | 149 M | 149 M | 149 M | 149 M | 142 M | 142 M | 142 M | 142 M |
Total Shareholders Equity |
6.53 M | 7.41 M | 7.45 M | 6.11 M | 4.35 M | 4.67 M | 4.29 M | 2.83 M | 4.02 M | 5.34 M | 6.02 M | 6.85 M | 6.52 M | 7.17 M | 8 M | 8 M | 8 M | 8 M | 9.24 M | 9.24 M | 9.24 M | 9.24 M | 30.2 M | 30.2 M | 30.2 M | 30.2 M | 43.1 M | 43.1 M | 43.1 M | 43.1 M | 58.9 M | 58.9 M | 58.9 M | 58.9 M | 72.6 M | 72.6 M | 72.6 M | 72.6 M | 92.7 M | 92.7 M | 92.7 M | 92.1 M | 133 M | 133 M | 133 M | 133 M | 149 M | 149 M | 149 M | 149 M | 142 M | 142 M | 142 M | 142 M |
All numbers in USD currency